249 related articles for article (PubMed ID: 26181795)
1. Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model.
Moore JH; Pinheiro CC; Zaenker EI; Bolick DT; Kolling GL; van Opstal E; Noronha FJ; De Medeiros PH; Rodriguez RS; Lima AA; Guerrant RL; Warren CA
PLoS One; 2015; 10(7):e0131829. PubMed ID: 26181795
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Warren CA; van Opstal EJ; Riggins MS; Li Y; Moore JH; Kolling GL; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2013 Feb; 57(2):689-96. PubMed ID: 23147742
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.
van Opstal E; Kolling GL; Moore JH; Coquery CM; Wade NS; Loo WM; Bolick DT; Shin JH; Erickson LD; Warren CA
J Infect Dis; 2016 Jul; 214(1):130-9. PubMed ID: 26917573
[TBL] [Abstract][Full Text] [Related]
4. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW
Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463
[TBL] [Abstract][Full Text] [Related]
5. Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates
Schnizlein MK; Vendrov KC; Edwards SJ; Martens EC; Young VB
mSphere; 2020 Jan; 5(1):. PubMed ID: 31915217
[TBL] [Abstract][Full Text] [Related]
6. Outbreak of Murine Infection with
Mau T; Eckley SS; Bergin IL; Saund K; Villano JS; Vendrov KC; Snitkin ES; Young VB; Yung R
mSphere; 2019 Mar; 4(2):. PubMed ID: 30894434
[TBL] [Abstract][Full Text] [Related]
7. Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection.
Zackular JP; Moore JL; Jordan AT; Juttukonda LJ; Noto MJ; Nicholson MR; Crews JD; Semler MW; Zhang Y; Ware LB; Washington MK; Chazin WJ; Caprioli RM; Skaar EP
Nat Med; 2016 Nov; 22(11):1330-1334. PubMed ID: 27668938
[TBL] [Abstract][Full Text] [Related]
8. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains.
Theriot CM; Koumpouras CC; Carlson PE; Bergin II; Aronoff DM; Young VB
Gut Microbes; 2011; 2(6):326-34. PubMed ID: 22198617
[TBL] [Abstract][Full Text] [Related]
9. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.
Buffie CG; Jarchum I; Equinda M; Lipuma L; Gobourne A; Viale A; Ubeda C; Xavier J; Pamer EG
Infect Immun; 2012 Jan; 80(1):62-73. PubMed ID: 22006564
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model.
Moore JH; van Opstal E; Kolling GL; Shin JH; Bogatcheva E; Nikonenko B; Einck L; Phipps AJ; Guerrant RL; Protopopova M; Warren CA
J Antimicrob Chemother; 2016 May; 71(5):1300-6. PubMed ID: 26832756
[TBL] [Abstract][Full Text] [Related]
11. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
[TBL] [Abstract][Full Text] [Related]
12. Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.
Theriot CM; Schumacher CA; Bassis CM; Seekatz AM; Young VB
Antimicrob Agents Chemother; 2015 Mar; 59(3):1596-604. PubMed ID: 25547352
[TBL] [Abstract][Full Text] [Related]
13. Administration of probiotic kefir to mice with Clostridium difficile infection exacerbates disease.
Spinler JK; Brown A; Ross CL; Boonma P; Conner ME; Savidge TC
Anaerobe; 2016 Aug; 40():54-7. PubMed ID: 27180007
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of hamsters to Clostridium difficile isolates of differing toxinotype.
Buckley AM; Spencer J; Maclellan LM; Candlish D; Irvine JJ; Douce GR
PLoS One; 2013; 8(5):e64121. PubMed ID: 23704976
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro studies of Clostridium difficile-induced disease in hamsters fed an atherogenic, high-fat diet.
Blankenship-Paris TL; Chang J; Dalldorf FG; Gilligan PH
Lab Anim Sci; 1995 Feb; 45(1):47-53. PubMed ID: 7752614
[TBL] [Abstract][Full Text] [Related]
16. Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
Ajami NJ; Cope JL; Wong MC; Petrosino JF; Chesnel L
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463537
[No Abstract] [Full Text] [Related]
17. Pre-colonization with the commensal fungus Candida albicans reduces murine susceptibility to Clostridium difficile infection.
Markey L; Shaban L; Green ER; Lemon KP; Mecsas J; Kumamoto CA
Gut Microbes; 2018 Nov; 9(6):497-509. PubMed ID: 29667487
[TBL] [Abstract][Full Text] [Related]
18. Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model.
Hryckowian AJ; Van Treuren W; Smits SA; Davis NM; Gardner JO; Bouley DM; Sonnenburg JL
Nat Microbiol; 2018 Jun; 3(6):662-669. PubMed ID: 29686297
[TBL] [Abstract][Full Text] [Related]
19. Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile.
Engevik MA; Engevik KA; Yacyshyn MB; Wang J; Hassett DJ; Darien B; Yacyshyn BR; Worrell RT
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G497-509. PubMed ID: 25552580
[TBL] [Abstract][Full Text] [Related]
20. A High-Carbohydrate Diet Prolongs Dysbiosis and Clostridioides difficile Carriage and Increases Delayed Mortality in a Hamster Model of Infection.
Bhute SS; Mefferd CC; Phan JR; Ahmed M; Fox-King AE; Alarcia S; Villarama JV; Abel-Santos E; Hedlund BP
Microbiol Spectr; 2022 Aug; 10(4):e0180421. PubMed ID: 35708337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
